The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2023 | Tools to improve frailty assessment in patients with multiple myeloma
Elizabeth O’Donnell, MD, Dana-Farber Cancer Institute, Boston, MA, discusses tools used to assess frailty in patients with multiple myeloma, such as the International Myeloma Working Group (IMWG) frailty score and the Charlson Comorbidity Index (CCI), and further comments on the importance of incorporating these tools into clinical trial design. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
